Early stage research and low turnaround dominates

Nordic science parks are full of advanced research performed by small companies but little research is done in later stages. Only a couple of the best performers have companies in phase III, according to Biotech Scandinavia's survey.

International models among science parks

Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Countries with a clear research goal are investing in new parks, and in China, the number is growing exponentially.

EU-stöd till svenska forskare

Tolv svenska forskare får stöd från det Europeiska forskningsrådet, ERC.

Fortfarande ont om kvinnor

Av de 236 beviljade projekten i europeiska forskningsrådets ERCs satsning är endast 15 procent kvinnor.

Här är hela listan med de svenska ERC-miljonerna

Totalt har 236 forskare fått pengar från det europeiska forskningsrådet ERC. Tolv av dem kommer att arbeta med sina projekt i Sverige.

Ökat söktryck hos Emea

Stockholm-Uppsala life science cluster in brief

Stockholm-Uppsala evolves around the research at Karolinska Institutet and Uppsala University. Typical areas of research are protein research, neuroscience and cancer.

Nytt system hanterar sekvenseringsdata

Dagens avancerade tekniker för sekvensering av DNA gör att det behövs nya system för att lagra de enorma mängder data som samlas. På Uppmax i Uppsala finns ett resurscentrum som hanterar merparten genetiska data från Uppsala universitet.

Life science in Stockholm

Sweden has the fourth-largest biotech market in Europe. More than half of its biotechnology enterprise, some 460 companies, is located in the Stockholm region.

Prestigepris till norsk cancerforskare

Tilldelas ett femårigt mångmiljonstöd från det europeiska forskningsrådet ERC.

Kliniskt diagnostest för sjukhussjukan

LightCycler MRSA Advanced Test från Roche testar förekomsten av MRSA, som orsakar det som allmänt kallas för sjukhussjukan.

Tigran får fransk order

Genom partnerbolaget Advanced Medical Products har Tigran tagit i sin hittills största order sedan försäljningsstarten ifjol.

AMO får nya ägare

Abbott köper Advanced Medical Optics som byter namn till Abbott Medical Optics.

Pfizer lays a chunky bid on Wyeth

The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at approximately $68 billion. The Boards of Directors of both companies have said yes to the deal that may lead to lay-offs of some 8,000 persons.

Grant for development projects in Gothenburg

Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Finnish-Dutch engineering cooperation continues

The University of Helsinki and ASM International renew a fice year research agreement on Atomic Layer Deposition.

Medtech companies find new beam technique

The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.

Abbott expands by acquisition

An acquisition gives Abbott a leadership position in another large and growing medical device segment.

Dupont gets new business manager

The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.

Transatlantic cooperation for healthier food

Danish and American scientists are going to work together to find ways to fight malnutrition and life style disease like obesity in the western world.

Transatlantic cooperation for healthier food

Danish and American scientists are going to work together to find ways to fight malnutrition and life style disease like obesity in the western world.

Vitrolife wants to acquire Medicult

The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.

Parnevik firm in Swiss osteoporosis deal

The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.